These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3012403)

  • 1. Prolonged CNS hyperexcitability in mice after a single exposure to delta-9-tetrahydrocannabinol.
    Karler R; Calder LD; Turkanis SA
    Neuropharmacology; 1986 Apr; 25(4):441-6. PubMed ID: 3012403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice.
    Karler R; Turkanis SA
    Br J Pharmacol; 1980 Mar; 68(3):479-84. PubMed ID: 6301593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between delta-9-tetrahydrocannabinol and kindling by electrical and chemical stimuli in mice.
    Karler R; Calder LD; Sangdee P; Turkanis SA
    Neuropharmacology; 1984 Nov; 23(11):1315-20. PubMed ID: 6098847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant activity of delta9-tetrahydrocannabinol compared with three other drugs.
    Sofia RD; Solomon TA; Barry H
    Eur J Pharmacol; 1976 Jan; 35(1):7-16. PubMed ID: 1253828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central excitatory properties of delta 9-tetrahydrocannabinol and its metabolites in iron-induced epileptic rats.
    Turkanis SA; Karler R
    Neuropharmacology; 1982 Jan; 21(1):7-13. PubMed ID: 6278353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant activities of delta-8 and delta-9 tetrahydrocannabinol and uridine.
    Dwivedi C; Harbison RD
    Toxicol Appl Pharmacol; 1975 Mar; 31(3):452-8. PubMed ID: 1145630
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.
    Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H
    Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
    Watanabe K; Yamamoto I; Yoshimura H
    Eur J Pharmacol; 1983 Oct; 94(3-4):349-51. PubMed ID: 6317407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activity of delta9-tetrahydrocannabinol, diphenylhydantoin, phenobarbital and chlordiazepoxide on electroshcok seizure threshold in mice.
    Sofia RD; Barry H
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):73-8. PubMed ID: 921404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune function in mice tolerant to or abstinent from l-trans-delta 9-tetrahydrocannabinol.
    Bhargava HN; House RV; Thorat SN; Thomas PT
    Pharmacology; 1996 May; 52(5):271-82. PubMed ID: 8807671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of 22-day treatment on the anticonvulsant properties of cannabinoids.
    Karler R; Borys HK; Turkanis SA
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Aug; 320(2):105-9. PubMed ID: 6289137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of chronic treatment and withdrawal of CNS depressants on aggressive behavior.
    Yen-Koo HC; Tocus EC; Balazs T
    Toxicol Ind Health; 1989 Dec; 5(6):953-6. PubMed ID: 2560590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of brain histamine in delta 9-tetrahydrocannabinol tolerance and withdrawal.
    Verberne AJ; Fennessy MR; Lewis SJ; Taylor DA
    Pharmacol Biochem Behav; 1985 Aug; 23(2):153-9. PubMed ID: 2997805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats.
    Colasanti BK; Lindamood C; Craig CR
    Pharmacol Biochem Behav; 1982 Apr; 16(4):573-8. PubMed ID: 6280204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) leads to changes in opioid-related behavioral patterns in rats.
    Vela G; Fuentes JA; Bonnin A; Fernández-Ruiz J; Ruiz-Gayo M
    Brain Res; 1995 May; 680(1-2):142-7. PubMed ID: 7663970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic delta-9-tetrahydrocannabinol. Transient and lasting effects on avoidance behavior.
    Manning RJ
    Pharmacol Biochem Behav; 1976 Jan; 4(1):17-21. PubMed ID: 1265092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
    Dhawan K; Kumar S; Sharma A
    J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil.
    Rundfeldt C; Wlaź P; Hönack D; Löscher W
    J Pharmacol Exp Ther; 1995 Nov; 275(2):693-702. PubMed ID: 7473156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.